BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 27443811)

  • 1. Ultrasonographic diagnosis and longitudinal follow-up of recurrences after conservative surgery for borderline ovarian tumors.
    Franchi D; Boveri S; Radice D; Portuesi R; Zanagnolo V; Colombo N; Testa AC
    Am J Obstet Gynecol; 2016 Dec; 215(6):756.e1-756.e9. PubMed ID: 27443811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery for young patients with borderline ovarian tumors (BOTs): single institution experience.
    Chen RF; Li J; Zhu TT; Yu HL; Lu X
    J Ovarian Res; 2016 Mar; 9():16. PubMed ID: 26988551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound, physical examination, and CA 125 measurement for the detection of recurrence after conservative surgery for early borderline ovarian tumors.
    Zanetta G; Rota S; Lissoni A; Meni A; Brancatelli G; Buda A
    Gynecol Oncol; 2001 Apr; 81(1):63-6. PubMed ID: 11277651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conservative surgery in ovarian borderline tumours: a meta-analysis with emphasis on recurrence risk.
    Vasconcelos I; de Sousa Mendes M
    Eur J Cancer; 2015 Mar; 51(5):620-31. PubMed ID: 25661104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.
    Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P
    BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Borderline ovarian tumors: French guidelines from the CNGOF. Part 2. Surgical management, follow-up, hormone replacement therapy, fertility management and preservation.
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; D'argent Mathieu E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    J Gynecol Obstet Hum Reprod; 2021 Jan; 50(1):101966. PubMed ID: 33144266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retrospective analysis of the clinical outcomes in 12 recurrent borderline ovarian tumor patients with second fertility-sparing surgery].
    Chen R; Zhu T; Yu H; Zhu J; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2014 Apr; 49(4):254-9. PubMed ID: 24969331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of borderline ovarian tumours.
    Gershenson DM
    Best Pract Res Clin Obstet Gynaecol; 2017 May; 41():49-59. PubMed ID: 27780698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility sparing surgery for ovarian tumors in children and young adults.
    Abdel-Hady el-S; Abdel-Hady Hemida R; Gamal A; El-Shamey M
    Arch Gynecol Obstet; 2012 Feb; 285(2):469-71. PubMed ID: 21701836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature.
    Ludovisi M; Foo X; Mainenti S; Testa AC; Arora R; Jurkovic D
    J Clin Ultrasound; 2015; 43(9):573-7. PubMed ID: 25706035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging in gynecological disease (8): ultrasound characteristics of recurrent borderline ovarian tumors.
    Franchi D; Boveri S; Fruscio R; Fischerova D; Guerriero S; Moruzzi MC; Colombo N; Timmerman D; Valentin L; Testa AC
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):452-8. PubMed ID: 22858859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What women want: Fertility sparing surgery in Borderline ovarian tumours patients and pregnancy outcome.
    Candotti G; Peiretti M; Mangili G; Bergamini A; Candiani M; Cioffi R; Mais V; Rabaiotti E; Bocciolone L
    Eur J Surg Oncol; 2020 May; 46(5):888-892. PubMed ID: 31722834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pregnancy outcome and recurrence after conservative laparoscopic surgery for borderline ovarian tumors.
    Tinelli FG; Tinelli R; La Grotta F; Tinelli A; Cicinelli E; Schönauer MM
    Acta Obstet Gynecol Scand; 2007; 86(1):81-7. PubMed ID: 17230294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline tumors of the ovary: fertility treatment, conservative management, and pregnancy outcome.
    Gotlieb WH; Flikker S; Davidson B; Korach Y; Kopolovic J; Ben-Baruch G
    Cancer; 1998 Jan; 82(1):141-6. PubMed ID: 9428490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline ovarian tumors: Guidelines from the French national college of obstetricians and gynecologists (CNGOF).
    Bourdel N; Huchon C; Abdel Wahab C; Azaïs H; Bendifallah S; Bolze PA; Brun JL; Canlorbe G; Chauvet P; Chereau E; Courbiere B; De La Motte Rouge T; Devouassoux-Shisheboran M; Eymerit-Morin C; Fauvet R; Gauroy E; Gauthier T; Grynberg M; Koskas M; Larouzee E; Lecointre L; Levêque J; Margueritte F; Mathieu D'argent E; Nyangoh-Timoh K; Ouldamer L; Raad J; Raimond E; Ramanah R; Rolland L; Rousset P; Rousset-Jablonski C; Thomassin-Naggara I; Uzan C; Zilliox M; Daraï E
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():492-501. PubMed ID: 33262005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-Guided Laparoscopic Ovarian Wedge Resection in Recurrent Serous Borderline Ovarian Tumours.
    Jones BP; Saso S; Farren J; El-Bahrawy M; Ghaem-Maghami S; Smith JR; Yazbek J
    Int J Gynecol Cancer; 2017 Nov; 27(9):1813-1818. PubMed ID: 28763365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors for recurrence after conservative treatment in a series of 119 patients with stage I serous borderline tumors of the ovary.
    Uzan C; Muller E; Kane A; Rey A; Gouy S; Bendiffallah S; Duvillard P; Fauvet R; Darai E; Morice P
    Ann Oncol; 2014 Jan; 25(1):166-71. PubMed ID: 24287939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of fertility-sparing surgery for stage II and III serous borderline ovarian tumors.
    Lu Z; Li B; Gu C
    J Int Med Res; 2019 Oct; 47(10):4895-4903. PubMed ID: 31432738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.